New Delhi, February 08, 2018: The organization had posted a benefit after assessment of Rs 194.9 crore for the comparing time of the past monetary, Natco Pharma said in a BSE documenting.
Medication firm Natco Pharma today detailed a 11.54 for each penny ascend in its united benefit after assessment at Rs 217.4 crore for the quarter finished December 2017.
The organization had posted a benefit after assessment of Rs 194.9 crore for the relating time of the past monetary, Natco Pharma said in a BSE recording.
Solidified aggregate incomes of the organization remained at Rs 573.6 crore for the quarter under thought against Rs 685.1 crore in a similar period a year prior.
The organization in a different recording stated, its board has announced second interval profit of Rs 7 on every value offer of Rs 2 for the year 2017-18. Offers of Natco Pharma were exchanging 1.05 for every penny down at Rs 903.70 for every scrip on BSE.
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…